SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

PayPal Holdings, Inc. engages in the development of technology platforms that enable digital payments and simplifies commerce experiences on behalf of merchants and consumers worldwide. Its solutions include PayPal, PayPal Credit, Braintree, Venmo, Xoom, and Paydiant products. The firm also enables consumers to exchange funds with merchants using funding sources, which include bank account, PayPal account balance, PayPal Credit account, credit, and debit card or other stored value products. It operates through United States and Other Countries geographical segments. The company was founded in December 1998 and is headquartered in San Jose, CA.

PayPal Holdings Inc

PayPal is trending amid ongoing speculation of a potential acquisition by a group including Stripe and Advent, with the community actively debating whether management will secure a premium valuation. Traders are closely monitoring institutional call sweeps and technical breakouts, viewing the stock as a deeply undervalued asset ripe for a higher buyout offer or a significant long-term turnaround.

Iovance Biotherapeutics, Inc. is a biopharmaceutical company, which engages in the development and commercialization of cell therapies as novel cancer immunotherapy products. Its lead product candidate, LN-144 for metastatic melanoma, is an autologous adoptive cell therapy utilizing tumor-infiltrating lymphocytes (TIL), which are T cells derived from patients' tumors. The company was founded by Robert T. Brooke on September 17, 2007 and is headquartered in San Carlos, CA.

Iovance Biotherapeutics Inc

Iovance Biotherapeutics is trending following a massive surge in institutional accumulation and positive institutional ownership filings, fueling community sentiment that the stock is poised for a significant re-rating. Investors are hyper-focused on the company's strong revenue guidance, expanding ATC network, and upcoming registrational data for non-small cell lung cancer, which many view as a transformative catalyst for long-term valuation.

Broadcom Inc. is a global technology company, which designs, develops, and supplies semiconductors and infrastructure software solutions. It operates through the Semiconductor Solutions and Infrastructure Software segments. The Semiconductor Solutions segment refers to product lines and intellectual property licensing. The Infrastructure Software segment relates to mainframe, distributed and cyber security solutions, and fibre channel storage area networking business. The company was founded in 1961 and is headquartered in Palo Alto, CA.

Broadcom Inc

Broadcom is experiencing significant volatility driven by investor concerns over security vulnerabilities in its VMware products alongside broader semiconductor sector pressure. Despite these challenges, the community remains actively divided, with many traders viewing the price dips as buying opportunities due to the company's strong long-term fundamentals in AI chip revenue and networking.

XRP is a decentralized digital asset and the native token of the XRP Ledger, a Layer 1 blockchain designed for high-performance global payments. Its primary value proposition is offering a fast, cost-effective alternative to traditional banking systems by enabling near-instant cross-border settlements that finalize in three to five seconds. By serving as a neutral bridge asset between different fiat currencies, it helps financial institutions lower liquidity costs and eliminates the need for pre-funded accounts.  The network is unique because it utilizes a federated consensus protocol instead of energy-intensive mining or staking. This system achieves deterministic finality through a Unique Node List of trusted validators who must reach an eighty percent agreement threshold to permanently record transactions. This infrastructure supports a sustained throughput of 1,500 transactions per second and includes a built-in decentralized exchange that allows for the automated trading of any tokenized asset without intermediaries.  The project traces its origins back to 2004 with Ryan Fugger before being co-founded in its modern form by Jed McCaleb and Chris Larsen. The company, now known as Ripple, works with major financial institutions as partners and investors to build global payment solutions. To protect the network from spam, a small amount of XRP is burned during every transaction, and the token is further utilized by institutions as collateral to access traditional markets and manage digital asset infrastructure.  Institutional adoption of the asset reached a major milestone in November 2025 when the SEC approved the first wave of spot XRP ETFs. These products, offered by major issuers including Bitwise, Grayscale, 21Shares, Canary Capital, and Franklin Templeton, are now listed on prominent exchanges like the NYSE Arca, Nasdaq, and Cboe BZX. While Ripple remains a key contributor to the ecosystem, the underlying XRP Ledger continues to operate as an open-source and decentralized network.

Ripple

XRP is currently facing intense selling pressure, dropping below the psychological $1 mark, which has triggered widespread debate among community members regarding its long-term utility versus its potential as a speculative asset. While some investors are utilizing the dip to average down their positions, many others are expressing frustration over perceived lack of leadership and market manipulation, leading to a polarized outlook on whether this represents a major buying opportunity or a deeper correction.

Netlist, Inc. engages in the design, manufacture and sale of memory subsystems for the computing and communications markets. Its products include enterprise SSD, embedded flash, memory module, lightning DDR5 DIMM, SK hynix, AI server. The company was founded by Jayesh Bhakta, Chun Ki Hong and Christopher Lopes in June 2000 and is headquartered in Irvine, CA.

Netlist Inc

Netlist is trending as retail investors rally behind the stock following a landmark patent settlement with Samsung and renewed legal pressure on major memory manufacturers. The community is actively discussing the stock's significant long-term potential, with many members anticipating a short squeeze and further licensing deals as key catalysts for sustained growth.

Gorilla Technology Group, Inc. engages in the provision of video intelligence, Internet of Things (IoT) security, edge AI data analytics, and operational technology security solutions and services in Asia Pacific. It operates through the following segments: Video IoT, Security Convergence, and Other. The company was founded by Spincer Koh in May 2001 and is headquartered in London, the United Kingdom.

Gorilla Technology Group Inc

Gorilla Technology is trending as investors monitor heavy short interest and speculative anticipation for upcoming quarterly results, with the community actively debating whether the companys recent AI infrastructure expansion can trigger a potential squeeze or major revaluation. While some vocal bears point to historical concerns regarding dilution and management communication, bulls are emphasizing strong revenue growth trends and the strategic positioning of their data center projects as catalysts for a significant turnaround.

iShares Trust - iShares Russell 2000 Index Fund

iShares Russell 2000 ETF

The IWM is trending as small caps rally alongside major indices, with the community actively debating whether this outperformance signals a broader market rotation or remains a speculative 'bull trap' despite persistent concerns over yields and economic data.

Unusual Machines, Inc. is a development stage technology company, which engages in the provision of drone solutions with a focus on first-person view (FPV) technology. It offers products to entertainment, recreation, and competitive racing industries. The company was founded on July 11, 2019, and is headquartered in Orlando, FL.

Unusual Machines Inc

Unusual Machines is surging as investors react to a significant government policy catalyst involving new tariffs on imported drones, which is expected to bolster domestic manufacturing and defense-related supply chains. The community is actively debating the stock's potential as a long-term defense play, with heavy discussions revolving around recent analyst coverage, insider alignment through new performance-based compensation, and broader industry growth.

CorMedix, Inc. is a pharmaceutical and medical device company, which engages in the development and commercialization of therapeutic products for the prevention and treatment of diseases and conditions. The company was founded by Antony E. Pfaffle on July 28, 2006 and is headquartered in Berkeley Heights, NJ.

CorMedix Inc

CorMedix is trending as investors weigh strong Q2 results, highlighted by robust revenue and raised EBITDA guidance, against ongoing volatility driven by sector-specific reimbursement uncertainty. While community discussions remain deeply polarized between long-term bulls highlighting institutional accumulation and DaVita's contract win versus skeptics frustrated by share price suppression and lack of leadership transparency.

EyePoint, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapeutics that treat eye disorders. It offers FDA-approved sustained-release treatments in ophthalmology under the DEXYCU, ILUVIEN, Verisome, Retisert, and Durasert brands. The company was founded in 1987 and is headquartered in Watertown, MA.

EyePoint Inc.

EyePoint Pharmaceuticals Inc

EyePoint Pharmaceuticals is trending as investors monitor heavy volume and abnormal price activity ahead of the anticipated Phase 3 LUGANO trial readout. The community is actively debating the potential for a short squeeze given the high institutional ownership and significant short float, while balancing enthusiasm for clinical milestones against caution regarding upcoming dilution and competitive data.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

COO vs. MMSI: Which Stock Should Value Investors Buy Now?

COO vs. MMSI: Which Stock Is the Better Value Option?

MMSI Q2 Earnings & Revenues Beat Estimates, '26 Guidance Raised

Merit Medical's Q2 adjusted EPS jumps 18% as revenues rise 9.5%, margins expand and 2026 guidance increases after broad product growth.

These Analysts Increase Their Forecasts On Merit Medical Systems After Strong Q2 Results

Merit Medical Systems Inc (NASDAQ: MMSI) reported strong Q2 earnings, beating estimates with raised guidance. Analysts maintain Buy ratings with increased price targets.read more...

Merit Medical (MMSI) Surpasses Q2 Earnings and Revenue Estimates

Merit Medical (MMSI) delivered earnings and revenue surprises of +23.96% and +3.50%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Merit Medical (MMSI) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates

The headline numbers for Merit Medical (MMSI) give insight into how the company performed in the quarter ended June 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

Watch These 4 Medical Product Stocks for Q2 Earnings: Beat or Miss?

Medical product makers face Q2 margin pressure from tariffs and inflation even as demand stays strong. See which earnings reports could surprise.

MMSI vs. WST: Which Stock Should Value Investors Buy Now?

MMSI vs. WST: Which Stock Is the Better Value Option?

Here's Why Merit Medical (MMSI) is a Strong Growth Stock

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Here's Why Merit Medical (MMSI) is a Strong Value Stock

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Here's Why You Should Add Merit Medical Stock to Your Portfolio Now

MMSI's portfolio, acquisitions, R&D strategy and WRAPSODY upside support growth, though tariffs, China pressure and OEM headwinds persist.

Merit Medical Systems, Inc. engages in the manufacture and marketing of proprietary disposable medical devices. It operates through the Cardiovascular and Endoscopy segments. The Cardiovascular segment consists of peripheral intervention, cardiac intervention, interventional oncology and spine, and cardiovascular and critical care product groups. The Endoscopy segment integrates non-vascular stent technology with balloon dilators, inflation devices, guide wires, procedure kits, and other devices that are used by gastroenterologists, endoscopists, pulmonologists, and thoracic and general surgeons. The company was founded by Fred P. Lampropoulos, Darla Gill, Kent W. Stanger, and William Padilla in July 1987 and is headquartered in South Jordan, UT.

Merit Medical Systems, Inc.

Merit Medical Stock Soars After Hours As Better-Than-Expected Q2 Guidance Outweighs CEO Exit

Equity

Neutral Sentiment

Up more than 1% 

Flat to up 1%

Flat to down 1%

Down more than 1%

The S&P 500 ($SPY) is headed towards a winning week. What do you think the index's return will look like next week? Vote and explain your reasoning in the comments.

What do you think the S&amp;P 500&#39;s ($SPY) return will be next week?

Current Price	$90.76
Prev Close	$90.50
Open	$90.86
Dividend Yield	0.00%
50-Day Moving Average	$74.23
Beta	0.74
Avg. Volume	856,935.64
PE Ratio	37.30

52-Week High	$94.75
52-Week Low	$59.74
Market Capitalization	$5.4B
EPS (Annual)	$2.13
Price to Book	3.22
Revenue Per Employee	$201,964.00

Feed

News

Sentiment

Earnings

Fundamentals

Info